Fairpointe Capital LLC

Holdings History for NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO)

Symbol: NEO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2021	3.3%	0%	$2,170,000	45,000	0		$48.22	Q1 2021
31 Dec 2020	0.45%	0%	$2,423,000	45,000	0		$53.84	Q4 2020
30 Sep 2020	0.27%	-0.09%	$1,660,000	45,000	-15,000	-25%	$36.89	Q3 2020
30 Jun 2020	0.27%	-0.41%	$1,859,000	60,000	-90,000	-60%	$30.98	Q2 2020
31 Mar 2020	0.62%	0%	$4,141,000	150,000	0		$27.61	Q1 2020
31 Dec 2019	0.34%	-0.05%	$4,387,000	150,000	-23,277	-13%	$29.25	Q4 2019
30 Sep 2019	0.17%	-0.03%	$3,313,000	173,277	-30,000	-15%	$19.12	Q3 2019
30 Jun 2019	0.18%	-0.01%	$4,460,000	203,277	-7,530	-3.6%	$21.94	Q2 2019
31 Mar 2019	0.14%	0%	$4,313,000	210,807	0		$20.46	Q1 2019
31 Dec 2018	0.09%	-0.03%	$2,658,000	210,807	-67,325	-24%	$12.61	Q4 2018
30 Sep 2018	0.11%	0%	$4,269,000	278,132	0		$15.35	Q3 2018
30 Jun 2018	0.08%	0%	$3,646,000	278,132	0		$13.11	Q2 2018
31 Mar 2018	0.05%	0%	$2,270,000	278,132	0		$8.16	Q1 2018
31 Dec 2017	0.05%	+0.05%	$2,464,000	278,132	+278,132	NEW	$8.86	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.